SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-072178
Filing Date
2007-04-02
Accepted
2007-04-02 16:12:57
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1375626
2 MANUFACTURING AGREEMENT WITH PRODUITS CHEMQUES AUXILIAIRES ET DE SYNTHESE SA dex1015.htm EX-10.15 80699
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1555
4 CERTIFICATION PURSUANT TO RULE 13A-14(A) OF JOSEPH K. BELANOFF, M.D. dex311.htm EX-31.1 8615
5 CERTIFICATION PURSUANT TO RULE 13A-14(A) OF FRED KURLAND dex312.htm EX-31.2 8734
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 OF JOSEPH K. BELANOFF, M.D. dex321.htm EX-32.1 3614
7 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 OF FRED KURLAND dex322.htm EX-32.2 3483
8 GRAPHIC g53049g65c94.jpg GRAPHIC 35549
  Complete submission text file 0001193125-07-072178.txt   1532673
Mailing Address
Business Address 275 MIDDLEFIELD ROAD SUITE A MENLO PARK CA 94025
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658
Type: 10-K | Act: 34 | File No.: 000-50679 | Film No.: 07739148
SIC: 2834 Pharmaceutical Preparations